Xopenex Side Effects
>>>Help Community - Post Your Xopenex Side Effect
More Rx Information: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZAsk about Xopenex Side Effects
Xopenex Safety Reports reported to FDA
Total Xopenex reports: 125.Xopenex FDA safety alerts: No.
Reported deaths: 5 Reported hospitalizations: 112.
Take Xopenex Side Effects Survey or Share Your Xopenex Story.
Reported Xopenex Side Effects: chronic obstructive pulmonary disease, condition aggravated, blood glucose increased, bronchitis, haemoglobin decreased, haematocrit decreased, dyspnoea, dyspnoea exertional, pneumonia aspiration, pneumonia, nausea.
Xopenex Usage.
If you have questions about Xopenex, you can ask a Health Expert or Ask Patient Community about Xopenex.
< Previous Showing 101-125 of 125
Xopenex Side Effects Report #5168830-9Physician from UNITED STATES reported XOPENEX problem on Nov 17, 2006. Male patient, 60 years of age, weighting 198.4 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood ph increased, chronic obstructive pulmonary disease, condition aggravated, cough, dyspnoea, heart rate increased, hepatic steatosis. XOPENEX dosage: unknown. During the same period patient was treated with ATORVASTATIN, METOPROLOL SUCCINATE, VALSARTAN, PANTOPRAZOLE, INSULIN, ASPIRIN, FLONASE. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5178909-3
XOPENEX problem was reported by a Physician from UNITED STATES on Nov 28, 2006. Male patient, 71 years of age, weighting 119.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, chronic obstructive pulmonary disease, electrocardiogram poor r-wave progression, electrocardiogram t wave inversion, sinus tachycardia, troponin increased. XOPENEX dosage: unknown. During the same period patient was treated with THEOPHYLLINE, ALBUTEROL, ATROVENT, PREDNISONE, PULMICORT, TAMSULOSIN, ALBUTEROL W, GUAIFENESIN. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5186527-6
Consumer or non-health professional from UNITED STATES reported XOPENEX problem on Nov 30, 2006. Female patient was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hyperventilation, musculoskeletal stiffness. XOPENEX dosage: unknown. Patient recovered.
Xopenex Side Effects Report #5195674-4
XOPENEX problem was reported by a Physician from UNITED STATES on Dec 06, 2006. Female patient, 69 years of age, weighting 233.5 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease. XOPENEX dosage: unknown. During the same period patient was treated with FLUOXETINE, PIROXICAM, CALCIUM, VITAMIN CAP, ASPIRIN, OXYGEN. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5382909-8
Physician from UNITED STATES reported XOPENEX problem on June 28, 2007. Male patient, 70 years of age, weighting 177.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, condition aggravated, heart rate irregular. XOPENEX dosage: unknown. During the same period patient was treated with SIMVASTATIN, REQUIP, DOXAZOSIN MESYLATE, ATROVENT. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5382911-6
XOPENEX problem was reported by a Physician from UNITED STATES on June 28, 2007. Male patient, 70 years of age, weighting 177.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, condition aggravated, heart rate irregular. XOPENEX dosage: unknown. During the same period patient was treated with SIMVASTATIN, REQUIP, DOXAZOSIN MESYLATE, ATROVENT. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5382913-X
Physician from UNITED STATES reported XOPENEX problem on Feb 28, 2007. Female patient, 74 years of age, weighting 162.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, eosinophil percentage increased, haematocrit decreased, haemoglobin decreased, hilar lymphadenopathy, lung neoplasm, lymphadenopathy mediastinal, lymphocyte percentage decreased. XOPENEX dosage: unknown. During the same period patient was treated with CALCIUM CHLORIDE, ASPIRIN, PRILOSEC, TYLENOL, FORMOTEROL FUMARATE, ALBUTEROL, ATACAND, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5382922-0
XOPENEX problem was reported by a Physician from UNITED STATES on June 25, 2007. Female patient, 74 years of age, weighting 162.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, computerised tomogram abnormal, condition aggravated, eosinophil count increased, eosinophil percentage increased, haematocrit decreased, haemoglobin decreased, hilar lymphadenopathy, lymphadenopathy mediastinal. XOPENEX dosage: unknown. During the same period patient was treated with CALCIUM CHLORIDE, ASPIRIN, PRILOSEC, TYLENOL, FORMOTEROL FUMARATE, ALBUTEROL, ATACAND, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5386067-5
Physician from UNITED STATES reported XOPENEX problem on July 02, 2007. Female patient, 77 years of age, weighting 192.5 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: asthenia, blood glucose increased, blood pressure systolic increased, chest pain, hyperhidrosis, nausea, protein urine present, rhonchi, sleep apnoea syndrome. XOPENEX dosage: unknown. During the same period patient was treated with LISINOPRIL, LUNESTA, ASPIRIN, IBUPROFEN, ATROVENT, DOLOMITE, VITAMIN B CAP, PRAVASTATIN. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5397557-3
XOPENEX problem was reported by a Pharmacist from UNITED STATES on July 24, 2007. Female patient, weighting 162.0 lb, was diagnosed with asthma and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, confusional state, dizziness, headache, hyperhidrosis, muscle spasms, nausea, pollakiuria. XOPENEX dosage: unknown. Patient recovered.
Xopenex Side Effects Report #5404137-X
Consumer or non-health professional from UNITED STATES reported XOPENEX problem on July 20, 2007. Female patient was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: pulmonary fibrosis. XOPENEX dosage: 1.25 MG/3ML; PRN; INHALATION. During the same period patient was treated with OXYGEN. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5404139-3
XOPENEX problem was reported by a Consumer or non-health professional from UNITED STATES on July 20, 2007. Female patient was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: pulmonary fibrosis. XOPENEX dosage: 1.25 MG/3 ML; PRN; INHALATION. During the same period patient was treated with OXYGEN. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5404435-X
Consumer or non-health professional from UNITED STATES reported XOPENEX problem on May 03, 2007. Male patient, 66 years of age, was diagnosed with bronchitis, chronic obstructive pulmonary disease, emphysema and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: breath odour, dysgeusia, heart rate increased, viral infection. XOPENEX dosage: 1.25 MG3ML;TID;INHALATION. During the same period patient was treated with XOPENEX HFA, XOPENEX HFA, XOPENEX HFA, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5407921-1
XOPENEX problem was reported by a Physician from UNITED STATES on July 25, 2007. Male patient, 70 years of age, weighting 177.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, coronary artery disease, coronary artery occlusion, electrocardiogram st-t change, oxygen saturation decreased, troponin increased. XOPENEX dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, REQUIP, DOXAZOSIN MESYLATE. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5407923-5
Consumer or non-health professional from UNITED STATES reported XOPENEX problem on July 24, 2007. Female patient, 86 years of age, weighting 105.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: blood sodium decreased, ill-defined disorder, rash, unevaluable event. XOPENEX dosage: 1.25 MG; INHALATION. During the same period patient was treated with TIOTROPIUM, PULMICORT, OXYGEN, LISINOPRIL, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5409020-1
XOPENEX problem was reported by a Physician from UNITED STATES on July 26, 2007. Male patient, 70 years of age, weighting 177.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: arrhythmia, atrial tachycardia, blood pressure increased, cardiac disorder, chest discomfort, chronic obstructive pulmonary disease, coronary artery disease, heart rate increased, respiratory rate increased. XOPENEX dosage: unknown. During the same period patient was treated with SIMVASTATIN, REQUIP, DOXAZOSIN MESYLATE, ATROVENT. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5409470-3
Physician from UNITED STATES reported XOPENEX problem on July 25, 2007. Male patient, 76 years of age, weighting 177.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: foreign body trauma, haematocrit decreased, haemoglobin decreased, oesophageal discomfort, oesophageal food impaction, spinal osteoarthritis. XOPENEX dosage: unknown. During the same period patient was treated with SIMVASTATIN, LORCET, GEMFIBROZIL, TAMSULOSIN, PRINZIDE, CYANOCOBALAMIN, TYLENOL, PAROXETINE. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5409593-9
XOPENEX problem was reported by a Physician from UNITED STATES on July 25, 2007. Male patient, 76 years of age, weighting 177.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: calcinosis, dysphagia, foreign body trauma, haematocrit decreased, haemoglobin decreased, oesophageal discomfort, oesophageal food impaction, renal failure, spinal osteoarthritis. XOPENEX dosage: unknown. During the same period patient was treated with SIMVASTATIN, LORCET, GEMFIBROZIL, TAMSULOSIN, PRINZIDE, CYANOCOBALAMIN, TYLENOL, PAROXETINE. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5441459-0
Consumer or non-health professional from UNITED STATES reported XOPENEX problem on June 19, 2007. Male patient, 84 years of age, weighting 140.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: emphysema, panic disorder, respiratory tract infection. XOPENEX dosage: 1.25 MG/3ML; 1X; INHALATION. During the same period patient was treated with ALBUTEROL, FOLIC ACID, HYZAAR, VITAMIN CAP, TIOTROPIUM BROMIDE, OXYGEN. Patient died on 07/09/2007.
Xopenex Side Effects Report #5442835-2
XOPENEX problem was reported by a Physician from UNITED STATES on Aug 16, 2007. Male patient, 57 years of age, weighting 309.7 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, leukocytosis. XOPENEX dosage: unknown. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5442836-4
Consumer or non-health professional from UNITED STATES reported XOPENEX problem on Aug 16, 2007. Male patient, 65 years of age, was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: bronchiectasis, cardiac arrest, chronic obstructive pulmonary disease, clostridium difficile colitis, fungal infection, hyperkalaemia, lung infection, lung infiltration, pneumonia. XOPENEX dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, PREDNISONE, BROVANA. Patient was hospitalized. Patient died on 08/21/2007.
Xopenex Side Effects Report #5444082-7
XOPENEX problem was reported by a Physician from UNITED STATES on Aug 20, 2007. Male patient, 68 years of age, weighting 254.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: bronchitis, condition aggravated. XOPENEX dosage: unknown. During the same period patient was treated with LASIX, AVAPRO, VITAMIN B CAP, NEXIUM, ATROVENT, LEVITRA. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5452028-0
Physician from UNITED STATES reported XOPENEX problem on Aug 28, 2007. Male patient, 50 years of age, weighting 161.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, acute myocardial infarction, blood albumin decreased, blood cholesterol increased, blood potassium decreased, blood urea increased, cardiac failure congestive, cardiac ventricular disorder, coronary artery occlusion. XOPENEX dosage: unknown. During the same period patient was treated with ALBUTEROL, PEPTO, IBUPROFEN, ATROVENT. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5472155-1
XOPENEX problem was reported by a Health Professional from UNITED STATES on Sept 10, 2007. Male patient, 72 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, dyspnoea, oxygen saturation decreased, rales, respiratory disorder, respiratory fume inhalation disorder, wheezing, white blood cell count increased. XOPENEX dosage: 1.25 MG/3ML; INHALATION; 1.25 PRN; INHALATION; 0.63 QID, INHALATION. During the same period patient was treated with PREDNISONE, TAMSULOSIN, HYDROCHLORIDE, ALPRAZOLAM, FORMOTEROL FUMARATE, BROVANA, ALBUTEROL W. Patient was hospitalized. Patient recovered.
Xopenex Side Effects Report #5472173-3
Health Professional from UNITED STATES reported XOPENEX problem on Sept 10, 2007. Male patient, 72 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, condition aggravated, respiratory fume inhalation disorder, white blood cell count increased. XOPENEX dosage: 1.25 MG/3ML; ; INHALATION, 1.25; PRN; INHALATION, 0.63; QID; INHALATION. During the same period patient was treated with PREDNISONE, TAMSULOSIN HYDROCHLORIDE, ALPRAZOLAM, FORMOTEROL FUMARATE, BROVANA, ALBUTEROL W, DILTIAZEM. Patient was hospitalized. Patient recovered.
< Previous Showing 101-125 of 125
Drug Information: Levalbuterol Oral Inhalation
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a603025.html
(lev al byoo' ter ol)Why is this medication prescribed?
Levalbuterol is used to prevent or relieve the wheezing, difficulty breathing, and chest tightness caused by lung disease such as asthma and chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways). Levalbuterol is in a class of medications called beta agonists. It works by relaxing and opening air passages to the lungs to make breathing easier.
How should this medicine be used?
Levalbuterol comes as a solution (liquid) to inhale by mouth using a nebulizer (machine that turns medication into a mist that can be inhaled), a concentrated solution to be mixed with normal saline and inhaled by mouth using a nebulizer, and as an aerosol to inhale by mouth using an inhaler. The solution for oral inhalation is usually used three times a day, once every 6-8 hours. The inhaler is usually used every 4-6 hours. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use levalbuterol exactly as directed. Do not use more or less of it or use it more often than prescribed by your doctor.
If your asthma symptoms become worse, if levalbuterol inhalation becomes less effective, or if you need more doses than usual of the asthma medications you use as needed, your condition may be getting worse.Do not use extra doses of levalbuterol. Call your doctor right away.
Levalbuterol controls symptoms of asthma and other lung diseases but does not cure these conditions. Continue to use levalbuterol even if you feel well. Do not stop using levalbuterol without talking to your doctor.
If you are using the inhaler, your medication will come in canisters. Each canister of levalbuterol aerosol is designed to provide 200 inhalations. After the labeled number of inhalations has been used, later inhalations may not contain the correct amount of medication. Throw away the canister after you have used the labeled number of inhalations even if it still contains some liquid and continues to release a spray when it is pressed.
You will need to keep track of the number of inhalations you have used. You can divide the number of inhalations in your inhaler by the number of inhalations you use each day to find out how many days your inhaler will last. Do not float the canister in water to see if it still contains medication.
The inhaler that comes with levalbuterol aerosol is designed for use only with a canister of albuterol. Never use it to inhale any other medication, and do not use any other inhaler to inhale levalbuterol.
Be careful not to get levalbuterol inhalation into your eyes.
Do not use your levalbuterol inhaler when you are near a flame or source of heat. The inhaler may explode if it is exposed to very high temperatures.
Before you use levalbuterol for the first time, read the written instructions that come with the inhaler or nebulizer. Ask your doctor, pharmacist, or respiratory therapist to show you how to use it. Practice using the inhaler or nebulizer while he or she watches.
If your child will be using the inhaler, be sure that he or she knows how to use it. Watch your child each time he or she uses the inhaler to be sure that he or she is using it correctly.
To use the aerosol inhaler, follow these steps:
- Remove the protective dust cap from the end of the mouthpiece. Check the mouthpiece for dirt or other objects. Be sure that the canister is fully and firmly inserted in the mouthpiece.
- Shake the inhaler well.
- If you are using the inhaler for the first time or if you have not used the inhaler in more than 3 days, you will need to prime it. To prime the inhaler, press down on the canister four times to release four sprays into the air, away from your face. Be careful not to get albuterol in your eyes.
- Breathe out as completely as possible through your mouth.
- Hold the canister with the mouthpiece on the bottom, facing you, and the canister pointing upward. Place the open end of the mouthpiece into your mouth. Close your lips tightly around the mouthpiece.
- Breathe in slowly and deeply through the mouthpiece.At the same time, press down once on the container with your middle finger to spray the medication into your mouth.
- As soon as the medication is released, remove your finger from the canister and remove the mouthpiece from your mouth.
- Try to hold your breath for 10 seconds.
- If you were told to use two puffs, wait 1 minute and then repeat steps 4-8.
- Replace the protective cap on the inhaler.
To use the solution or the concentrated solution for oral inhalation, follow these steps:
- Open the foil pouch by tearing through the rough edge along the side of the pouch and remove one vial. Leave the rest of the vials inside the foil pouch to protect them from light. Look at the solution in the vial to be sure it is colorless. If it is not colorless, call your doctor or pharmacist and do not use the solution.
- Twist off the top of the vial and squeeze all of the liquid into the reservoir of your nebulizer. Do not add any other medications to the nebulizer because it may not be safe to mix them with levalbuterol. Use all nebulized medications separately unless your doctor specifically tells you to mix them.
- If you are using the concentrated solution, add the amount of normal saline that your doctor told you to use to the reservoir. Gently swirl the nebulizer to mix the normal saline and the concentrated solution.
- Connect the nebulizer reservoir to your mouthpiece or facemask.
- Connect the nebulizer to the compressor.
- Sit upright and place the mouthpiece in your mouth or put on the facemask.
- Turn on the compressor.
- Breathe calmly, deeply, and evenly until mist stops forming in the nebulizer. This should take between 5 and 15 minutes.
- Clean the nebulizer according to the manufacturer's instructions.
Clean your inhaler or nebulizer regularly. Follow the manufacturer's directions carefully and ask your doctor or pharmacist if you have any questions about cleaning your inhaler or nebulizer. If you do not clean your inhaler properly, the inhaler may become blocked and may not spray medication. If this happens, follow the manufacturer's directions for cleaning the inhaler and removing the blockage.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before using levalbuterol,
- tell your doctor and pharmacist if you are allergic to levalbuterol, albuterol (Proventil, Ventolin, others), or any other medications.
- tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: beta blockers such as atenolol (Tenormin), labetalol (Normodyne), metoprolol (Lopressor, Toprol XL), nadolol (Corgard), and propranolol (Inderal); digoxin (Digitek, Lanoxin); diuretics ('water pills'); epinephrine (Epipen, Primatene Mist); medications for colds; and other inhaled medications to relax the air passages such as metaproterenol (Alupent) and pirbuterol (Maxair). Also tell your doctor or pharmacist if you are taking the following medications or if you have stopped taking them within the past 2 weeks: antidepressants such as amitriptyline (Elavil), amoxapine (Asendin), clomipramine (Anafranil), desipramine (Norpramin), doxepin (Sinequan), imipramine (Tofranil), nortriptyline (Aventyl, Pamelor), protriptyline (Vivactil), and trimipramine (Surmontil); and monoamine oxidase inhibitors such as isocarboxazid (Marplan), phenelzine (Nardil), tranylcypromine (Parnate), and selegiline (Eldepryl, Emsam, Zelapar). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
- tell your doctor if you have or have ever had high blood pressure, irregular heartbeat, any other type of heart disease, seizures, diabetes, hyperthyroidism (condition in which there is too much thyroid hormone in the body), or kidney disease.
- tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while using levalbuterol, call your doctor.
- you should know that levalbuterol inhalation sometimes causes wheezing and difficulty breathing immediately after it is inhaled, especially the first time you use a new canister of albuterol aerosol. If this happens, call your doctor right away. Do not use levalbuterol inhalation again unless your doctor tells you that you should.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
Use the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not use a double dose to make up for a missed one.
What side effects can this medication cause?
Levalbuterol may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- headache
- dizziness
- nervousness
- uncontrollable shaking of a part of the body
- heartburn
- vomiting
- cough
- weakness
- fever
- diarrhea
- muscle pain
- leg cramps
Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately:
- chest pain
- fast or pounding heartbeat
- hives
- skin rash
- itching
- increased difficulty breathing or difficulty swallowing
- hoarseness
- swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs
Levalbuterol may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/index.html] or by phone [1-800-332-1088].
What storage conditions are needed for this medicine?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication. Do not puncture the aerosol container and do not discard it in an incinerator or fire.
Levalbuterol solution must be protected from light. Store unused vials in the foil pouch, and discard all unused vials 2 weeks after you open the pouch. If you remove a vial from the pouch, you should protect it from light and use it within 1 week.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
Symptoms of overdose may include:
- seizures
- chest pain
- fast, pounding, or irregular heartbeat
- nervousness
- headache
- dry mouth
- uncontrollable shaking of a part of the body
- nausea
- dizziness
- extreme tiredness
- weakness
- difficulty falling or staying asleep
What other information should I know?
Keep all appointments with your doctor.
Do not let anyone else use your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Brand name(s):
|
Other name(s):
|